{'fraction_non_alphanumeric': 0.021709633649932156, 'fraction_numerical': 0.005427408412483039, 'mean_word_length': 4.904, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Profile of Andrew R. Marks.

Heart failure is the leading cause of death in developed countries and is often caused by blockage of coronary arteries. One of the recent medical technology successes in battling cardiac disease has been the drug-eluting coronary artery stent, which acts as a scaffold to keep arteries open and releases therapeutic agents. The development of such drug-eluting stents was pioneered by cardiologist Andrew R. Marks, elected to the National Academy of Sciences (NAS) in 2005. A research scientist at Columbia University College of Physicians and Surgeons (New York), Marks is Chair of the Department of Cellular Physiology and Biophysics and Director of the Clyde and Helen Wu Center for Molecular Cardiology.